Multi-center, randomized, open-label and phase II study of bexarotene in patients with adult T-cell leukemia/lymphoma (ATL)
Latest Information Update: 07 Jan 2022
At a glance
- Drugs Bexarotene (Primary)
- Indications Adult T-cell leukaemia-lymphoma
- Focus Therapeutic Use
- Sponsors Minophagen
- 22 Dec 2021 New trial record